
Sign up to save your podcasts
Or
Today’s cancer therapies are difficult, expensive, and slow to create. But the combination of new computing and new biological technologies is leading to a better understanding of the human immune system, with the goal of offering a better class of cancer therapies.
Azeem Azhar speaks with Immunai co-founder and chief technology officer Luis Voloch about how AI is unlocking the secrets of the immune system and opening new avenues for novel cancer treatments.
They also discuss:
@Azeem
Further resources:
4.9
601601 ratings
Today’s cancer therapies are difficult, expensive, and slow to create. But the combination of new computing and new biological technologies is leading to a better understanding of the human immune system, with the goal of offering a better class of cancer therapies.
Azeem Azhar speaks with Immunai co-founder and chief technology officer Luis Voloch about how AI is unlocking the secrets of the immune system and opening new avenues for novel cancer treatments.
They also discuss:
@Azeem
Further resources:
242 Listeners
378 Listeners
1,268 Listeners
1,003 Listeners
513 Listeners
195 Listeners
3,963 Listeners
209 Listeners
1,408 Listeners
745 Listeners
1,265 Listeners
173 Listeners
397 Listeners
260 Listeners
101 Listeners
58 Listeners
643 Listeners
125 Listeners
438 Listeners
29 Listeners